VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
166 hedge funds and large institutions have $372M invested in Verve Therapeutics in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 64 increasing their positions, 47 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
6.97% less ownership
Funds ownership: 97.62% → 90.65% (-7%)
43% less call options, than puts
Call options by funds: $576K | Put options by funds: $1M
66% less capital invested
Capital invested by funds: $1.08B → $372M (-$712M)
Holders
166
Holding in Top 10
2
Calls
$576K
Puts
$1M
Top Buyers
| 1 | +$15.9M | |
| 2 | +$6.08M | |
| 3 | +$4.42M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$2.44M |
| 5 |
Goldman Sachs
New York
|
+$2.23M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$11.7M | |
| 3 | -$9.58M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$8.53M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$7.21M |